Zecotek Photonics (Zecotek Photonics) FCF Margin % : 19.44% (As of Apr. 2020)

View and export this data going back to 2003. Start your Free Trial

What is Zecotek Photonics FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Zecotek Photonics's Free Cash Flow for the three months ended in Apr. 2020 was $0.01 Mil. Zecotek Photonics's Revenue for the three months ended in Apr. 2020 was $0.04 Mil. Therefore, Zecotek Photonics's FCF Margin % for the quarter that ended in Apr. 2020 was 19.44%.

As of today, Zecotek Photonics's current FCF Yield % is 0.00%.

The historical rank and industry rank for Zecotek Photonics's FCF Margin % or its related term are showing as below:

ZMSPF' s FCF Margin % Range Over the Past 10 Years
Min: -1396.62 Med: 0 Max: 0
Current: -1396.62

ZMSPF's FCF Margin % is not ranked
in the Medical Devices & Instruments industry.
Industry Median: -7.19 vs ZMSPF: -1396.62

Zecotek Photonics FCF Margin % Historical Data

The historical data trend for Zecotek Photonics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zecotek Photonics FCF Margin % Chart

Zecotek Photonics Annual Data

Trend

Jul10

Jul11

Jul12

Jul13

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

FCF Margin %

Get a 7-Day Free Trial

-951.57

-253.77

-783.42

-3,144.16

-6,862.07

Zecotek Photonics Quarterly Data
	Jul15	Oct15	Jan16	Apr16	Jul16	Oct16	Jan17	Apr17	Jul17	Oct17	Jan18	Apr18	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20
FCF Margin %	Get a 7-Day Free Trial															-	-1,155.17	-5,318.18	-3,457.14	19.44

Competitive Comparison of Zecotek Photonics's FCF Margin %

For the Medical Devices subindustry, Zecotek Photonics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zecotek Photonics's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Zecotek Photonics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Zecotek Photonics's FCF Margin % falls into.

Zecotek Photonics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Zecotek Photonics's FCF Margin for the fiscal year that ended in Jul. 2019 is calculated as

FCF Margin	=	Free Cash Flow (A: Jul. 2019 )	/	Revenue (A: Jul. 2019 )
	=	-5.97	/	0.087
	=	-6,862.07 %

Zecotek Photonics's FCF Margin for the quarter that ended in Apr. 2020 is calculated as

FCF Margin	=	Free Cash Flow (Q: Apr. 2020 )	/	Revenue (Q: Apr. 2020 )
	=	0.007	/	0.036
	=	19.44 %

Zecotek Photonics FCF Margin % Related Terms

Thank you for viewing the detailed overview of Zecotek Photonics's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Zecotek Photonics (Zecotek Photonics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Zecotek Photonics Inc (OTCPK:ZMSPF) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

6900 Graybar Road, Unit 2325, Richmond, BC, CAN, V6W 0A5

Website

http://www.zecotek.com

Zecotek Photonics Inc is in the business of research and development of photonics technologies. The company is focused on creating advanced materials and integrated optoelectronic devices for high-resolution medical imaging, optical precision surgery, and biopharmaceutical research. It operates in three divisions which include Imaging systems, Optronics systems, and 3D display systems with labs located in Canada, Korea, Russia, Singapore, and the U.S.A. The company develops products such as scintillation crystals, solid-state, photodetectors, positron emission tomography scanning components, lasers, and 3D display and 3D printing technologies. These products are used in sectors such as healthcare, scientific and industrial.